当前位置:首页 - 行情中心 - 中国高科(600730) - 财务分析 - 利润表

中国高科

(600730)

  

流通市值:54.03亿  总市值:54.03亿
流通股本:5.87亿   总股本:5.87亿

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入21,938,223.57150,590,453.9996,480,572.3870,719,751.03
  营业收入21,938,223.57150,590,453.9996,480,572.3870,719,751.03
二、营业总成本21,745,345.04110,583,785.7578,431,287.7151,650,186.52
  营业成本5,980,537.6334,385,447.2222,664,348.5314,293,229.26
  税金及附加558,093.892,633,985.071,844,224.31,254,008.39
  销售费用4,370,893.1122,442,135.815,799,444.5810,504,726.26
  管理费用9,900,839.2346,069,788.9232,909,984.6719,674,646.73
  研发费用5,014,092.1917,617,608.7613,279,014.449,461,099.71
  财务费用-4,079,111.01-12,565,180.02-8,065,728.81-3,537,523.83
  其中:利息费用35,123.26133,024.376,190.5628,269.05
  其中:利息收入4,159,05313,039,255.458,427,457.183,801,673.15
三、其他经营收益
  加:公允价值变动收益497,693.76-5,947,568.927,156,382.844,306,362.04
  加:投资收益123,557.6120,635,088.655,241,474.583,669,529.52
  资产处置收益-26,782.53-66,754.19-66,754.19-56,149.4
  资产减值损失(新)--42,958.51--
  信用减值损失(新)-357,660.05-132,895.6-253,317.6-278,044.55
  其他收益266,186.914,299,371.564,024,558.381,083,910.5
四、营业利润695,874.2358,750,951.2334,151,628.6827,795,172.62
  加:营业外收入105,315.52241,801.51240,505.82218,503.98
  减:营业外支出419.181,008,402.22840,900.58552,687.09
五、利润总额800,770.5757,984,350.5233,551,233.9227,460,989.51
  减:所得税费用1,618,338.045,692,036.943,615,075.742,269,989.97
六、净利润-817,567.4752,292,313.5829,936,158.1825,190,999.54
(一)按经营持续性分类
  持续经营净利润-817,567.4752,292,313.5829,936,158.1825,190,999.54
(二)按所有权归属分类
  归属于母公司股东的净利润488,175.8448,908,796.4126,691,521.9621,772,250.76
  少数股东损益-1,305,743.313,383,517.173,244,636.223,418,748.78
  扣除非经常损益后的净利润934,325.839,358,344.919,635,557.5111,101,121.38
七、每股收益
  (一)基本每股收益00.080.050.04
  (二)稀释每股收益00.080.050.04
八、其他综合收益-593.063,670.82-821.221,200.05
  归属于母公司股东的其他综合收益-593.063,670.82-821.221,200.05
九、综合收益总额-818,160.5352,295,984.429,935,336.9625,192,199.59
  归属于母公司股东的综合收益总额487,582.7848,912,467.2326,690,700.7421,773,450.81
  归属于少数股东的综合收益总额-1,305,743.313,383,517.173,244,636.223,418,748.78
公告日期2025-04-302025-03-192024-10-312024-08-31
审计意见(境内)标准无保留意见
TOP↑